Skip To Main Content
A. Igoni Barrett on Muck Rack

A. Igoni Barrett

As seen in: Der Spiegel, Al Jazeera English, taz, Literary Hub, AllAfrica, ADVFN, Star2.com, The Millions, The Valdosta Daily Times, Joplin Globe and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with A. Igoni

Contact A. Igoni, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Literary Hub " Whyteface

|
By A. Igoni Barrett
| Literary Hub Verified
Once upon a time, but not so long ago, there was a woman who disobeyed her father by loving another man. The hot slap of her rebellion was heightened by the gulf in the social positions of the two men from whom her bloodline sprang.
Open in Who Shared Issue with article?

What A. Igoni Barrett Learnt About Race as a Teen.

|
By A. Igoni Barrett
| The Republic Lagos
Nigerian writer, A. Igoni Barrett, is working on a new novel that picks up Furo Wariboko’s story four years after the events in his critically acclaimed debut, Blackass: ‘My forthcoming novel, Whyteface, haunted me for about eight years, though without my conscious awareness.
Open in Who Shared Issue with article?

Cessation Therapeutics Announces Oral Presentation of Preliminary Findings from First-in-Human Study of Anti-Fentanyl Monoclonal Antibody, CSX-1004

|
By A. Igoni Barrett, N. Jacob, P. Bremer, S. Hull
| Pipeline Review
Data presented at the annual meeting of the College on Problems of Drug Dependence CSX-1004 was well-tolerated across the entire dose range, with no dose-limiting toxicities CSX-1004 is advancing to a Phase 2 Study CHAPEL HILL, NC, USA I June 19, 2024 I Cessation Therapeutics, Inc.
Open in Who Shared View Duplicates (37) Issue with article?
See all 18 licensed articles (20 Total)